Schedule of Options to Employees and Non-Employees Under the Company’s Option Plan

A summary of the status of options to employees and non-employees (including directors and consultants) under the Company’s option plan as of June 30, 2026, and changes during the six month period then ended are presented below:

	Number of options			Weighted average exercise price		Aggregate intrinsic value		Weighted average remaining contractual life (years)

Outstanding at beginning of period		2,937,808		$	4.78	$	1,932		8.69
Granted		748,586		$	4.43
Exercised		(2,250	)	$	3.98	$	2
Forfeited		(46,743	)	$	6.84
Expired		(624	)	$	92.89

Outstanding at end of period		3,636,777		$	4.67	$	3,941		8.54
Exercisable options		1,524,936		$	5.61	$	1,367		7.97
Vested and expected to vest		3,636,777		$	4.67	$	3,941		8.54

Schedule of Warrants Exercisable into Ordinary Shares

As of June 30, 2026, all warrants, including the pre-funded warrants disclosed in Note 5c, are exercisable into Ordinary shares as follows:

Grant date	Warrants outstanding as of June 30, 2026		Average Exercise price per share ($)		Warrants exercisable as of June 30, 2026		Exercisable through

April 2022		5,193		12.60		5,193	April 2029
July 2022		1,298		12.60		1,298	April 2029
April 2022		40,000		3.61		40,000	August 2031
August 2024		471,605		3.61		471,605	August 2026 *)
June 2025		7,289,644		4.50		7,289,644	June 2027 *)

		7,807,740				7,807,740

*)	See Note 5c for warrants and pre-funded warrants that were exercised during the six-month period ended June 30, 2026.